Database: European Organisation for Research and Treatment of Cancer (EORTC) Compilation (European Union): Difference between revisions
(Created page with "<span style="display:none">forresearchers</span> <span style="display:none">europeanunion</span> <span style="display:none">isDatabase</span> Go back to European Union page '''Type of database:''' databaseType::genomics, databaseType::survey, databaseType::biobank. '''Primary purpose:''' To improve cancer treatment and patient outcomes by coordinating and conducting international clinical and translational research. '''Sponsor, manager or home institut...") |
No edit summary |
||
| Line 14: | Line 14: | ||
'''Cancer Areas of Interest:''' [[hasCancerType::C00-D48: All neoplasms]]. | '''Cancer Areas of Interest:''' [[hasCancerType::C00-D48: All neoplasms]]. | ||
'''Data access:''' [[dataAvailability::not publicly available]]. Instructions on how to access databases [https://www.eortc.org/contact/?related=General Click here to learn more]. | '''Data access:''' [[dataAvailability::not publicly available]], [https://www.eortc.org/clinical-research/ Click here to access]. Instructions on how to access databases [https://www.eortc.org/contact/?related=General Click here to learn more]. | ||
'''Contact information:''' [https://www.eortc.org/ | '''Contact information:''' [https://www.eortc.org/contact/?related=General Click here to learn more]. | ||
<span style="display:none">Mouth</span> | <span style="display:none">Mouth</span> | ||
Revision as of 17:31, 28 January 2026
Go back to European Union page
Type of database: genomics, survey, biobank.
Primary purpose: To improve cancer treatment and patient outcomes by coordinating and conducting international clinical and translational research.
Sponsor, manager or home institution: EORTC.
Type of information: Contains information from clinical trials and patient-reported outcomes aimed at improving cancer treatment and patient care. They include data on ongoing and completed trials, such as treatment strategies (chemotherapy, immunotherapy, radiotherapy, surgery), patient eligibility, and trial outcomes like survival rates and response to treatments. The databases also feature health-related quality of life assessments through specialized questionnaires, which measure the impact of cancer and its treatments on patients’ physical, emotional, and social well-being. Additionally, some projects include biomarker and genomic data to analyze how genetic profiles affect treatment efficacy. Click here to access.
Cancer Areas of Interest: C00-D48: All neoplasms.
Data access: not publicly available, Click here to access. Instructions on how to access databases Click here to learn more.
Contact information: Click here to learn more.
